HYDROXYPROGESTERONE CAPROATE OIL, injectable Solution, 250 mg/mL, syringe sizes: 4 mL; 5 mL; 6 mL; 10 mL; 16 mL; 18 mL; 20 mL; and 22 mL, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314
Published November 4, 2015 · Recall initiated: July 24, 2015
Summary
FDA records drug Class II recall D-0100-2016, published November 4, 2015 and initiated July 24, 2015. Recalling firm: JD & SN Inc., dba Moses Lake Professional Pharmacy; Status: Terminated; Reported quantity: 3 (4mL) syringes, 4 (5mL) syringes, 1 (6mL) syringe, 13 (10mL) syringes, 1 (16mL) syringe, 1 (18mL) syringe, 14 (20mL) syringes, 2 (22mL) syringes; Lot: t12182014@7, t12052014@12, t10312014@21, t10102014@21, t10072014@6, t09172014@30, t09152014@11, t08132014@13, t08112014@28, t07282014@28, t07282014@16, t07012015@7, t06302015@31, t06222015@17, t06112015@14, t06022015@17, t05182015@24, t05152015@19, t05072015@9, t04272015@19, t04232015@22, t04212015@16, t04162015@21, t04092015@2, t04022015@27, t03162015@16, t03052015@25, t03022015@13, t02272015@22, t02202015@23, t02172015@8, t02132015@19, 08202014@12, 05042015@11; t02062015@29, t03312015@5, t06052015@3, t06172015@47, t06292015@13, and t10232014@22, t07242014@6. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- JD & SN Inc., dba Moses Lake Professional Pharmacy
- Distributor
- Nationwide
- Lot
- t12182014@7, t12052014@12, t10312014@21, t10102014@21, t10072014@6, t09172014@30, t09152014@11, t08132014@13, t08112014@28, t07282014@28, t07282014@16, t07012015@7, t06302015@31, t06222015@17, t06112015@14, t06022015@17, t05182015@24, t05152015@19, t05072015@9, t04272015@19, t04232015@22, t04212015@16, t04162015@21, t04092015@2, t04022015@27, t03162015@16, t03052015@25, t03022015@13, t02272015@22, t02202015@23, t02172015@8, t02132015@19, 08202014@12, 05042015@11; t02062015@29, t03312015@5, t06052015@3, t06172015@47, t06292015@13, and t10232014@22, t07242014@6
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMETHIONINE/CHOLINE/INOSITOL, injectable Solution, 25/50/50 MG/ML, 10 mL syringes, Rx only, JD & SN Inc, DBANovember 4, 2015
- FDAPAPAVERINE/PHENTOLAMINE, Injectable Solution, 30MG/1MG/ML, 10 mL syringe, Rx only, JD & SN Inc, DBA Moses LakeNovember 4, 2015
- FDATESTOSTERONE/ANASTROZOLE, Pellet, 200/13 mg, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555November 4, 2015
- FDAPROGESTERONE, Pellet, 50mg, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St.November 4, 2015
- FDAHYDROXYCOBALAMINE/METHYLCOBALAMINE PF UNIT DOSE, Injectable Solution, 1.5/1.5 mg/0.25 mL per syringe, Rx only,November 4, 2015
- FDAMEDROXYPROGESTERONE ACETATE, injectable Solution,150MG/ML, 10mL syringe, Rx only, JD & SN Inc, DBA Moses LakeNovember 4, 2015
Questions about this recall
Was HYDROXYPROGESTERONE CAPROATE OIL, injectable Solution, 250 mg/mL, syringe sizes: 4 mL; 5 mL; 6 mL; 10 mL; 16 mL; 18 mL; 20 mL; and 22 mL, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314 recalled?
Yes. FDA published recall D-0100-2016 on November 4, 2015. Reported hazard: Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
What should I do if I have this product?
Voluntary: Firm initiated · Press Release